FDA warned D&C Seafood that its king mackerel, wahoo, barracuda, and cobia lacked required seafood safety controls for histamine, ciguatera toxin, and allergens.
What happened
FDA inspected the seafood processing facility in Venice, Louisiana, on July 26, 2021. The agency found the firm did not have required HACCP (seafood safety control) plans for king mackerel and wahoo to control histamine formation, for king mackerel and barracuda to control ciguatera toxin, or for all four fish to control undeclared allergens. The letter also says the firm did not submit a response to address these violations.
What FDA found
The firm did not have a written HACCP plan for king mackerel and wahoo to control histamine formation.
21 CFR 123.6(a) and (b)The firm did not have a written HACCP plan for king mackerel and barracuda to control ciguatera toxin.
21 CFR 123.6(a) and (b)The firm did not have a written HACCP plan for king mackerel, wahoo, barracuda, and cobia to control undeclared allergens.
21 CFR 123.6(a) and (b)
What FDA wants
Within 15 working days of receiving the letter, D&C Seafood must tell FDA in writing what steps it has taken to correct the violations and prevent recurrence, including related documentation. If it cannot complete corrections in that time, it must state why and when it will finish.
Who should pay attention
- seafood processors that handle king mackerel, wahoo, barracuda, or cobia
- distributors and retailers buying Gulf seafood
- brands relying on contract seafood processors for allergen and toxin controls
This is a summary. Read the original letter on fda.gov.